SNU-216 Cells
USUSD$550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | The SNU-216 cell line is a human gastric carcinoma model derived from a metastatic lymph node of a patient with moderately differentiated adenocarcinoma. This cell line is part of a panel of gastric carcinoma models established to study gastric cancer biology, particularly in the context of tumor antigen expression, genetic mutations, and therapeutic responses. SNU-216 cells exhibit an adherent growth pattern in culture, forming a heterogeneous diffuse monolayer with round-oval cellular morphology and a low nuclear-to-cytoplasmic ratio. Genetic analyses have revealed significant mutations in the SNU-216 cell line, including alterations in the TP53 gene. Specifically, a mutation in exon 6 has been identified, which likely impacts its tumor suppressor functions. Additionally, tumor antigen studies have shown that SNU-216 expresses high levels of carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA), with no detectable alpha-fetoprotein (AFP). These features make the cell line a valuable tool for studying the molecular and genetic characteristics of gastric cancer and for exploring diagnostic and therapeutic applications related to tumor markers. SNU-216 has also been included in the Cancer Cell Line Encyclopedia (CCLE), providing extensive genomic, transcriptomic, and pharmacological data. The cell line’s molecular profile has been utilized to predict sensitivities to targeted therapies and to investigate pathways such as those involving receptor tyrosine kinases and PI3K signaling. Its inclusion in this resource underlines its importance as a preclinical model for gastric cancer research and drug development. |
|---|---|
| 生物體 | Human |
| 組織 | Gastric |
| 疾病 | tubular adenocarcinoma |
| 應用 | Lymph node |
| 同義詞 | SNU216, NCI-SNU-216 |
特徵
| 年齡 | 46 years |
|---|---|
| 性別 | Female |
| 族裔 | Korean |
| 形態學 | Epithelial-like |
| 細胞類型 | Epithelial |
| 生長特性 | Adherent, monolayer |
監管數據
| 引用 | SNU-216 (Cytion catalog number 305630) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_3946 |
生物分子資料
| 突變譜 | Mutation: TP53, Simple, p.Val216Met (c.646G>A), Homozygous |
|---|
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% heat inactivated FBS |
| 解離試劑 | Accutase |
| 倍增時間 | 36 hours |
| 傳代培養 | Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37''''C for 3 to 5 minutes, add culture medium and collect the cells, transfer the medium into 15ml tube, centrifuge, aspirate the medium, resuspend the pellets with culture medium and dispense into the culture flask |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305630-101125 | 分析證明書 | 11. Dec. 2025 | 305630 |